Manfredi Marco, Gargano Giancarlo, Gismondi Pierpacifico, Ferrari Bernardino, Iuliano Silvia
Chief of Pediatric Unit, Maternal and Child Department, Azienda USL-IRCCS di Reggio Emilia, Sant'Anna Hospital, Castelnovo ne' Monti, Via Roma, 2, Reggio Emilia 42035, Italy.
Maternal and Child Department, Azienda USL-IRCCS di Reggio Emilia, ASMN Hospital, Reggio Emilia, Italy.
Therap Adv Gastroenterol. 2023 Apr 27;16:17562848231170052. doi: 10.1177/17562848231170052. eCollection 2023.
Current recommendations on () eradication in children differ from adults. In -infected adults, the eradication is always recommended because of the risk to develop gastrointestinal and non-gastrointestinal associated diseases. Instead, before treating infected children, we should consider all the possible causes and not merely focus on infection. Indeed, pediatric international guidelines do not recommend the in children. Therefore, gastroscopy with antimicrobial susceptibility testing by culture on gastric biopsies should be performed before starting the eradication therapy in children to better evaluate all the possible causes of the symptomatology and to increase the eradication rate. Whether antibiotic susceptibility testing is not available, gastroscopy is anyway recommended to better set any possible cause of symptoms and not simply focus on the presence of . In children the lower antibiotics availability compared to adults forces to treat based on antimicrobial susceptibility testing to minimize the unsuccessful rates. The main antibiotics used in children are amoxicillin, clarithromycin, and metronidazole in various combinations. In empirical treatment, triple therapy for 14 days based either on local antimicrobial susceptibility or on personal antibiotic history is generally recommended. Triple therapy with high dose of amoxicillin is a valid alternative choice, either in double resistance or in second-line treatment. Moving from therapeutic regimens used in adults, we could also select quadruple therapy with or without bismuth salts. However, all the treatment regimens often entail unpleasant side effects and lower compliance in children. In this review, the alternative and not yet commonly used therapeutic choices in children were also analyzed.
目前关于儿童幽门螺杆菌根除的建议与成人不同。在幽门螺杆菌感染的成人中,由于有发生胃肠道及非胃肠道相关疾病的风险,总是建议进行根除治疗。相反,在治疗感染儿童之前,我们应考虑所有可能的病因,而不仅仅关注幽门螺杆菌感染。事实上,儿科国际指南不建议对儿童进行幽门螺杆菌根除治疗。因此,在儿童开始根除治疗前,应进行胃镜检查并对胃活检组织进行培养以检测抗菌药物敏感性,以便更好地评估症状的所有可能病因并提高根除率。如果无法进行抗生素敏感性检测,无论如何都建议进行胃镜检查,以更好地确定症状的任何可能病因,而不仅仅关注幽门螺杆菌的存在。与成人相比,儿童可获得的抗生素种类较少,这就要求根据抗菌药物敏感性检测进行治疗,以尽量降低治疗失败率。儿童使用的主要抗生素是阿莫西林、克拉霉素和甲硝唑,有多种组合方式。在经验性治疗中,一般建议根据当地抗菌药物敏感性或个人抗生素使用史进行为期14天的三联疗法。高剂量阿莫西林三联疗法是双重耐药或二线治疗中的有效替代选择。从成人使用的治疗方案来看,我们也可以选择含或不含铋盐的四联疗法。然而,所有治疗方案往往都会给儿童带来不愉快的副作用且依从性较低。在本综述中,还分析了儿童中替代的且尚未普遍使用的治疗选择。